Previous Article | Next Article ![]()
J Bacteriol, January 1998, p. 350-358, Vol. 180, No. 2
Department of Microbiology and Immunology,
Albert B. Chandler Medical Center, University of Kentucky,
Lexington, Kentucky 40536-0084
Received 28 July 1997/Accepted 8 November 1997
Yersinia pestis produces a set of virulence proteins
(Yops and LcrV) that are expressed at high levels and secreted by a
type III secretion system (Ysc) upon bacterium-host cell contact, and four of the Yops are vectorially translocated into eukaryotic cells.
YopD, YopB, and YopK are required for the translocation process. In
vitro, induction and secretion occur at 37°C in the absence of
calcium. LcrH (also called SycD), a protein required for the stability
and secretion of YopD, had initially been identified as a negative
regulator of Yop expression. In this study, we constructed a
yopD mutation in both wild-type and secretion-defective
(ysc) Y. pestis to determine if the
lcrH phenotype could be attributed to the decreased
stability of YopD. These mutants were constitutively induced for
expression of Yops and LcrV, despite the presence of the secreted
negative regulator LcrQ, demonstrating that YopD is involved in
negative regulation, regardless of a functioning Ysc system. Normally,
secretion of Yops and LcrV is blocked in the presence of calcium. The
single yopD mutant was not completely effective in blocking
secretion: LcrV was secreted equally well in the presence and absence
of calcium, while there was partial secretion of Yops in the presence
of calcium. YopD is probably not rate limiting for negative regulation,
as increasing levels of YopD did not result in decreased Yop
expression. Overexpression of LcrQ in the yopD mutant had
no significant effect on Yop expression, whereas increased levels of
LcrQ in the parent resulted in decreased levels of Yops. These results
indicate that LcrQ requires YopD to function as a negative regulator.
Yersinia pestis, the
causative agent of plague, has a plasmid-encoded low-calcium response
(LCR) regulatory mechanism that governs the expression and secretion of
a set of virulence proteins in response to environmental conditions
(40). Contact with a eukaryotic cell triggers an increase in
LCR gene expression and the vectorial translocation of four of the
secreted Yops (Yersinia outer proteins) into the host cell
where they disrupt cellular signaling and other biochemistry necessary
for phagocytosis and the mobilization of an effective immune response
(8, 40). The maximal Yop expression and secretion induced by
bacterium-host cell contact is mimicked in vitro by the absence of
Ca2+ at 37°C; in the presence of millimolar
concentrations of Ca2+ Yop expression is down-regulated and
secretion is completely blocked.
The Yops and LcrV are secreted from the bacterial cell without
processing by a specific Yop secretion system (Ysc) that is encoded by
the LCR virulence plasmid (8, 40). The Ysc system belongs to
the recently identified class of type III, or contact-dependent, secretion systems of both animal and plant gram-negative pathogens. These systems are involved in direct delivery of bacterial proteins into the target cell (30, 52) and are extremely complex: at least 19 gene products are required for the Ysc (8, 40). Translocation into the eukaryotic cell involves YopB, YopK, and YopD
(18, 19, 21, 22, 25, 41, 51, 58). YopB may form a pore in
the target cell membrane, and YopK may modulate the size of this pore
(19, 25). YopD's function in translocation has not been
determined.
There have been several gene products identified that play a role in
LCR regulation. Thermal induction of LCR gene expression is mediated by
the transcriptional activator LcrF (6, 24). LcrF exhibits
sequence similarity to the AraC activator of Escherichia coli and has been shown to interact with several yop
promoters (7, 29). The Ysc system has been shown to have a
positive role on the LCR: expression of Yops in a ysc mutant
is down-regulated, even under conditions that normally promote maximal
expression (5, 10, 43-45). It is believed that this
connection between contact-triggered secretion and transcriptional
up-regulation is the secretion of a repressor (or antiactivator)
component through the Ysc (37, 42). This is analogous to the
export of an anti-sigma factor through the flagellar export apparatus
(which has homology to inner membrane components of type III secretion
systems) as a control of late-gene expression in flagellar biosynthesis
(26, 27). Two secreted proteins, LcrE and LcrG, appear to
regulate secretion of Yops and LcrV in response to environmental
Ca2+: mutations inactivating either protein cause secretion
at 37°C irrespective of Ca2+ levels, with a concomitant
loss of negative control over Yop and LcrV expression (13,
55). LcrE (also called YopN) is thought to act at the bacterial
surface, presumably as the Ca2+ sensor, although that
activity has not been directly demonstrated (13). The
majority of LcrG is located in the cytosol and is thought to block
secretion from the cytoplasmic side (37). LcrV, in addition
to functioning as an antihost protein, serves as a positive regulatory
protein (4, 46, 56). LcrV is able to directly interact with
LcrG and is thought to titrate LcrG away from the Ysc system, thus
counteracting LcrG's secretion block when elevated levels of LcrV are
produced upon induction of the LCR (37).
The secreted protein LcrQ has previously been proposed to be the
negative regulator whose secretion allows up-regulation of LCR
expression (42). The level of LcrQ in the cell has been demonstrated to correlate to the level of Yop expression; i.e., Yop
expression is maximal when LcrQ is depleted from the cell, while
elevated levels of LcrQ result in down-regulation of Yop expression
(42, 50). This is even true in a ysc lcrQ double mutant, which exhibits constitutive Yop expression, resulting in the
conclusion that LcrQ secretion through the Ysc system is required for
full induction of Yop expression (42). LcrQ is secreted from
the cell quickly and efficiently both in vitro and after infection of
HeLa cells (42). The regulatory function of LcrQ does not
require translocation across the target cell membrane, as a
yopB mutant had the same LCR induction as wild-type cells
upon host cell contact (42). LcrQ has not been demonstrated to bind DNA, nor does its deduced amino acid sequence contain any
DNA-binding motifs, and therefore, it most likely exerts its regulatory
effect in an indirect manner (50).
The intracellular protein LcrH (also called SycD) was originally
thought to be involved in the negative regulation of Yop and LcrV
expression (4, 48). The phenotype of an lcrH
mutant is constitutive induction of the LCR, as well as constitutive secretion of LcrV and partial secretion of YopM (4, 45, 48, 56). An lcrH mutation also caused a ysc
strain to become constitutively induced for LCR expression
(45). LcrH has subsequently been reported to be required for
the stabilization and secretion of YopD (61). This raises
the possibility that the lcrH phenotype is caused by the
decreased stability of YopD. Additional evidence suggesting that YopD
may be involved in regulation was the constitutive LCR induction caused
by a Genblock insertion into the 3' end of yopD
(4). However, this effect was attributed to a
destabilization of the lcrGVHyopBD transcript
(4). In this study, we constructed an essentially complete
deletion of the yopD open reading frame and characterized
the resulting mutant for LcrV and Yop expression and secretion. Our
data indicate that YopD is involved in the negative regulation of the
LCR, regardless of a functioning Ysc system. In addition, we
demonstrate that LcrQ's negative regulatory function is dependent on
the presence of YopD.
Bacterial strains, plasmids, primers, and growth conditions.
Bacterial strains and plasmids are shown in Table
1. Synthetic oligonucleotides are shown
in Table 2. Y. pestis strains were grown in heart infusion broth or on tryptose blood agar base medium (Difco Laboratories, Detroit, Mich.) for genetic manipulations. For physiological experiments, Y. pestis strains were grown
in exponential phase at 26°C in the defined medium TMH
(59) with or without Ca2+ for 7 to 9 generations
and then were diluted to an absorbance at 620 nm
(A620) of ca. 0.1 and grown to an
A620 of ca. 0.2. Cultures were then either held
at 26°C or shifted to 37°C for an additional 6 h before
harvesting. Unless otherwise indicated, E. coli strains were
grown in Luria-Bertani (LB) broth (53) or on LB agar plates. Bacteria containing antibiotic resistance markers were grown in the
presence of the appropriate antibiotic(s) at a final concentration of
25 µg/ml (chloramphenicol), 50 µg/ml (kanamycin), or 100 µg/ml (ampicillin and streptomycin).
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
YopD of Yersinia pestis Plays a Role in
Negative Regulation of the Low-Calcium Response in Addition to Its Role
in Translocation of Yops
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
TABLE 1.
Bacterial strains and plasmids used
TABLE 2.
DNA oligonucleotides
DNA methods. Plasmid DNA was isolated by a standard alkaline lysis procedure or by the use of Qiagen spin or midi-prep columns (Qiagen, Inc., Studio City, Calif.). Cloning methods were essentially as described previously (53). DNA fragments were purified from agarose gels by use of a Qiaquick gel extraction kit (Qiagen, Inc.). Electroporation of DNA into E. coli and Y. pestis was done as previously described (39). Gene amplification was performed with Taq polymerase (either from GibcoBRL, Gaithersburg, Md., or Boehringer Mannheim, Indianapolis, Ind.) or PFU polymerase (Stratagene, La Jolla, Calif.) in a Perkin-Elmer GeneAmp model 2400 thermocycler (Perkin-Elmer Cetus, Norwalk, Conn.). Unless stated otherwise, 30 cycles of amplification were used, with 1 cycle consisting of denaturing at 94°C for 15 s, annealing at 50°C for 15 s, and extension at 72°C for 15 s. Total bacterial DNA for gene amplification was prepared as previously described (31). Custom oligonucleotides were obtained either from Genosys Biotechnologies (The Woodlands, Tex.), Integrated DNA Technologies, Inc. (Coralville, Iowa), or the Macromolecular Structure Analysis Facility (University of Kentucky). DNA sequencing was performed at the Macromolecular Structure Analysis Facility.
Plasmid construction. DNA used for cloning was obtained from pCD1 of Y. pestis by amplification with customized oligonucleotide primers. Some of the primers were designed using the Yersinia pseudotuberculosis DNA sequence, since portions of the region utilized have not yet been sequenced in Y. pestis, and LCR loci typically exhibit at least 95% sequence identity between the two species. Unless stated otherwise, the high-fidelity PFU polymerase was used for amplification of DNA, and the extension time of the cycles was increased to 1 min per kb amplified.
pAW102 (
yopD) was created by the blunt-end cloning of the
DNA sequence flanking, but not including, yopD (ca. 950 bases upstream and ca. 700 bases downstream) into the EcoRV
site of suicide vector pUK4134 (54). The only DNA present
from the yopD gene was the last 6 nucleotides, coding for
the C-terminal amino acid and the stop codon. The DNA fragment for
cloning was obtained by recombinant PCR (23) in which
internal complementary primers encoded sequence immediately upstream
and downstream of the desired deletion of bases 1 through 915 of
yopD. YOPD
915B and YOPD
1A were the two internal
primers, and YOPB296A (which lay within upstream yopB) and
YOPDOUTDB (which lay downstream of yopD) were the two
outside primers; these primers were based on a Y. pseudotuberculosis sequence. The resulting fragment was 5' end
phosphorylated with T4 kinase (Promega, Madison, Wis.).
Plasmid pAW111 (encoding C-terminally histidine-tagged YopD) was
constructed by amplifying yopD with YOPD1SDA and YOPDHTAGB, which contained the first 26 bases and bases 893 to 918 (with a G-to-C
substitution at base 916 resulting in a conservative missense mutation
of leucine to valine at the C-terminal position) of Y. pseudotuberculosis yopD, respectively, plus a 5' end with an
unencoded NdeI (YOPD1SDA) or XhoI (YOPDHTAGB)
site. The PCR product was cleaved with NdeI and
XhoI and cloned into the NdeI and XhoI
sites of pET-24b (Novagen, Inc, Milwaukee, Wis.).
pAW171 (encoding N-terminally histidine-tagged YopD) was constructed by
amplifying yopD with YOPD1SDA and YOPD921B (which contained
the final 21 bases of Y. pseudotuberculosis yopD plus a 5'
end with an unencoded XbaI site). The PCR product was
cleaved with NdeI and XbaI and cloned into the
NdeI and XbaI sites of pProEX-1 (GibcoBRL).
Plasmid pAW161 (expressing yopD) was constructed by cloning
lcrH and yopD into NheI- and
XbaI-cleaved pBAD33 (16). The DNA fragment for
cloning was obtained by recombinant PCR amplification (23)
to delete bases 23 through 1169 of yopB, with YOPB
1169A and YOPB
23B as the two internal primers based on a Y. pseudotuberculosis sequence, and LCRH1SDA and YOPD921B based on
Y. pestis and Y. pseudotuberculosis sequences,
respectively, as the two outside primers, followed by digestion with
NheI and XbaI (both sites engineered as
nonencoded 5' ends of the outside primer sequences).
Plasmid pAW162 (expressing lcrQ) was constructed by
amplifying lcrQ with primers LCRQ1SDA and LCRQ348B derived
from the Y. pseudotuberculosis lcrQ sequence and containing
unencoded NheI and XbaI restriction sites in the
5' ends, respectively. The PCR product was cleaved with NheI
and XbaI and cloned into NheI- and XbaI-cleaved pBAD33.
pWGQ (encoding glutathione S-transferase [GST]-LcrQ) was
constructed by amplifying lcrQ with primers LCRQ1-2 and
LCRQ2-2 based on the Y. pestis lcrQ sequence and containing
5' unencoded EcoRI and BamHI restriction sites,
respectively. The PCR product was cleaved with EcoRI and
BamHI and cloned into EcoRI- and
BamHI-cleaved pGEX-3X (Pharmacia Biotech, Piscataway, N.J.).
Amplification of the DNA for pWGQ was performed with Taq
polymerase, and the annealing, extension, and denaturation times for
each cycle were 30 s (14).
Construction of mutants. Plasmid pAW102 was used for the deletion of the yopD gene. The plasmid was electroporated into Smr Y. pestis, and the yopD deletion was introduced into pCD1 by allelic exchange as previously described (54). The presence of second crossovers was screened for by PCR, and the presence of mutations was confirmed by DNA sequence analysis. The yopD mutation was introduced into Y. pestis KIM5-3001, KIM8-3002, and KIM5-3001.2, resulting in Y. pestis KIM5-3001.16, KIM8-3002.2, and KIM5-3001.2.1, respectively.
Cell fractionation. Cell pellets and culture supernatants of Y. pestis grown in TMH were separated by centrifugation at 4,000 × g for 16 min at 4°C. Cell pellets were washed once with ice-cold phosphate-buffered saline (PBS) (135 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4; pH 7.4). Whole-cell fractions were prepared by being resuspended in 1× protein sample buffer (SB) (2). Cellular extracts were made by disintegration of PBS-resuspended cell pellets in the ice-cold cell of a French press (20,000 lb/in2). Low-speed centrifugation (8,000 × g, 5 min, 4°C) removed unbroken cells and large debris. The total soluble fraction (cytoplasmic plus periplasmic) was separated from membranes by ultracentrifugation at 513,000 × g in a TLA120.2 rotor for 10 min at 4°C, using a Beckman Optima TLX ultracentrifuge (Beckman Instruments, Fullerton, Calif.). Culture supernatant proteins were precipitated either with 5% (wt/vol) trichloroacetic acid (TCA) for 4 h to overnight on ice or with 80% (wt/vol) ammonium sulfate overnight at 4°C. The TCA-precipitated samples were collected by centrifugation at 20,800 × g for 30 min at 4°C, neutralized, and resuspended in 1× SB. The ammonium sulfate-precipitated samples were resuspended in PBS, dialyzed against PBS at 4°C by using either a Slide-A-Lyzer 2,000-molecular-weight-cutoff cassette (Pierce, Rockford, Ill.) or Spectra/Por 4 dialysis tubing (Spectrum, Laguna Hills, Calif.), and added to an equal volume of 2× SB.
Antibody preparation.
Plasmid pAW111, which encodes a
C-terminally polyhistidine-tagged YopD (HT-YopD) behind the T7 promoter
of pET-24b (Novagen), and plasmid pTrcH5 (12), which
contains the lcrH gene behind the trc promoter of
pTrc99A (Pharmacia Biotech), were introduced into E. coli
BL21(DE3). Cultures (200 ml) were grown at 37°C in tryptone-phosphate
medium (35) to an A600 of ca. 0.6, at
which point high-level expression of the proteins was induced by the addition of isopropyl-
-D-thiogalactopyranoside (IPTG) to
1.0 mM followed by incubation at 37°C for an additional 7.5 h.
The cells were harvested by centrifugation at 11,300 × g for 10 min at 4°C. Cell pellets were resuspended in
lysis buffer (20 mM Tris-HCl [pH 8.0], 100 mM NaCl) and lysed by
passage through a French pressure cell (20,000 lb/in2).
Unlysed cells, large debris, and inclusion bodies were removed by
centrifugation at 8,000 × g for 5 min at 4°C. The
soluble fraction was loaded on a 1-ml Talon resin column (Clontech,
Palo Alto, Calif.), washed with 10 column volumes of lysis buffer, and
then washed with 10 column volumes of lysis buffer with 6 M
guanidinium-HCl to dissociate LcrH bound to HT-YopD (HT-YopD remains
bound to the Talon resin in the presence of 6 M guanidinium-HCl).
HT-YopD was eluted from the column in lysis buffer with 50 to 200 mM
imidazole, with subsequent dialysis against lysis buffer to remove the
imidazole. HT-YopD was purified to homogeneity by this procedure, as
assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) followed by silver staining (data not shown).
. Cultures (100 ml) were grown at 37°C in tryptone-phosphate medium to an A620 of ca. 0.4, at which point
high-level expression was induced by the addition of IPTG to 1.0 mM
followed by incubation at 37°C overnight. The cells were harvested by
centrifugation at 11,300 × g for 20 min at 4°C. Cell
pellets were resuspended in PBS and lysed by passage through a chilled
French pressure cell (20,000 lb/in2). The soluble fraction,
which contained the majority of GST-LcrQ, was obtained by
ultracentrifugation at 417,000 × g for 15 min in a
TLA100.4 rotor at 4°C. GST-LcrQ was purified on a glutathione column
(Pharmacia Biotech) as recommended by the manufacturer.
Anti-HT-YopD and anti-GST-LcrQ antibodies were raised in female New
Zealand White rabbits as previously described (36). Immunoglobulin G was affinity purified by chromatography on an Affi-Prep-protein A column (Bio-Rad, Hercules, Calif.) as recommended by the manufacturer. Anti-HT-YopD and anti-GST-LcrQ antibody
preparations were used for immunoblot analysis at dilutions of 1:40,000
and 1:20,000, respectively.
Protein electrophoresis and immunodetection. Proteins were separated by SDS-PAGE, with 12 or 15% (wt/vol) polyacrylamide gels as indicated, by the method of Laemmli (28). Samples containing whole-cell fractions were boiled for 5 min, while all other fractions were heated to ca. 95°C for 3 to 5 min prior to being loaded on the gels. Samples were loaded so as to contain amounts of the fractions derived from the same volume of original culture. Proteins separated by SDS-PAGE were transferred to an Immobilon-P membrane (Millipore Corp., Bedford, Mass.) with carbonate buffer (pH 9.9) (37). Specific proteins were visualized on the membranes as previously described (43) by using the polyclonal antibodies specific for the proteins and a secondary goat anti-rabbit antibody (Sigma Chemical, St. Louis, Mo.) conjugated to alkaline phosphatase.
| |
RESULTS |
|---|
|
|
|---|
Construction of a Y. pestis yopD null mutant.
To
test the hypothesis that YopD destabilization causes the negative
regulatory phenotype originally attributed to lcrH, a yopD deletion mutant was constructed (Fig.
1A). Recombinant PCR mutagenesis
(23) was used to delete essentially the entire open reading
frame to ensure that a partial gene product could not be expressed.
yopD occurs at the end of the lcrGVHyopBD operon, so there were no downstream genes to disrupt. However, the potential
-independent termination signal (4) was left intact to
ensure proper processing of the transcript. The only yopD
sequence retained was the 6 3'-terminal nucleotides in case that DNA
sequence is important for the termination signal. The yopD
deletion was introduced into pCD1 of Smr Y. pestis KIM8-3002 by allelic exchange, resulting in the strain KIM8-3002.2.
|
Expression and secretion of LCR gene products.
To determine
the role YopD plays in the LCR, Yop expression and secretion were
examined in both Y. pestis KIM8-3002.2 and its parent by
immunoblot analysis. The Y. pestis strains were grown in TMH
with or without Ca2+ at 26°C and then shifted to 37°C
for 6 h. After 6 h, all sample handling occurred at 4°C to
minimize additional protein synthesis. The protein profiles of whole
cells (containing the cytoplasmic, periplasmic, and membrane fractions)
and culture supernatant (obtained by TCA precipitation) were determined
with antibodies raised against YopM (36), LcrV
(37), and LcrQ (Fig. 2).
Similar results were seen if the culture supernatant fraction was
obtained by ammonium sulfate precipitation (data not shown). The
expression of YopM and LcrV was up-regulated in the mutant when grown
in the presence of Ca2+, indicating that YopD is required
for negative regulation. The results were similar when other Yops were
analyzed (YopE and YopH) (data not shown). When the samples were
examined for the presence of LcrQ, this putative negative regulator was
still detected in the cellular fraction of the mutant grown in the
presence of Ca2+ and in fact appeared to be at a higher
concentration than in the parent Yersinia. This represents a
situation where LcrQ does not cause down-regulation, suggesting that
YopD is required for LcrQ to exhibit its negative regulatory activity.
The elevated level of LcrQ likely reflects some effect of the LCR on
LcrQ expression. There was no difference in Yop expression between
wild-type and
yopD Y. pestis under normally inductive
conditions (the absence of Ca2+).
|
Localization of YopD. Soluble (periplasm and cytoplasm), total membrane, and supernatant fractions isolated from Y. pestis KIM8-3002 cultures were examined for the presence of YopD by immunoblot analysis (Fig. 1B). As expected, in the presence of Ca2+, when secretion is blocked and the LCR is repressed, no YopD was observed in the culture supernatant. Instead, there appeared to be comparable levels of YopD in both the soluble and membrane fractions. YopD has two predicted transmembrane spans (17), so it is not surprising to find it associated with the membrane. In contrast, in the absence of Ca2+, when secretion is not blocked and the LCR is maximally expressed, the majority of YopD was found in the culture supernatant. However, YopD could still be detected in the soluble fraction. This indicates that it is not necessary to completely deplete the cell of YopD to obtain increased LCR expression.
Expression of YopD in wild-type and yopD Y. pestis.
Complementation was performed to show that the phenotype of the
yopD mutant was solely due to its mutation. lcrH
and yopD were cloned in tandem behind the
arabinose-inducible promoter of pBAD33 (16) by amplifying
the region from pCD1 and using recombinant PCR mutagenesis
(23) to remove the entire yopB gene. The
rationale for including lcrH was that since the gene product had recently been demonstrated to be a chaperone for YopD
(61), lcrH may be required for efficient YopD
expression. Subsequent sequencing of the plasmid revealed a single-base
deletion in the start codon for lcrH, resulting in the
inability to express the gene. However, YopD was expressed in E. coli from the plasmid despite no LcrH expression (data not shown).
The plasmid was introduced into wild-type and
yopD Y. pestis. Despite the fact that a very low level of expression is
supposed to occur in the absence of induction of pBAD vectors
(16), YopD was expressed without the addition of arabinose,
although induction did result in an increase in YopD levels (Fig.
3).
|
yopD Y. pestis (data not shown).
Overexpressing YopD to significantly higher levels, such as when the
plasmid was induced with arabinose in wild-type cells, did result in an
apparent decrease in YopM expression. However, the growth rate of these
cells significantly decreased over time (data not shown). This decrease
in growth rate could be differentiated from the growth restriction
normally seen under LCR-inductive conditions, since the level of YopM
decreased rather than increased. It is possible that higher levels of
YopD are toxic to the bacterial cell. This makes it difficult to
interpret the significance of the lower level of YopM observed in these
cells containing high levels of YopD.
Effect of the yopD mutation in a ysc
strain.
Yop expression in a ysc mutant is
down-regulated, even under conditions that normally promote maximal
expression, presumably through the inability to secrete a negative
regulator (37, 42). A ysc lcrQ double mutant has
previously been reported to show constitutive Yop expression
(42). It was concluded that secretion of LcrQ is a
prerequisite to achieve maximal induction of Yop expression. Since YopD
also plays a role in negative regulation, a ysc yopD double
mutant was constructed to determine the role of secretion on the action
of YopD. The
yopD null mutation was moved into pCD1 of
Y. pestis KIM5-3001.2 (
lcrD) by allelic
exchange (LcrD is an essential component of the Ysc system [43,
44]). This strain contains pPCP1; however, the Pla protease
does not present difficulties in interpreting results for intracellular proteins.
lcrD parent and
lcrD
yopD strains
were analyzed for LCR expression and secretion (Fig.
4). As expected, the
lcrD
parent strain had a low level of LCR expression and no detectable
secretion. In contrast, the double mutant had high levels of
cell-associated YopM and LcrV, with neither protein detected in the
culture supernatant. These results indicate that the role YopD plays in
negative regulation occurs irrespective of the Ysc system. Also, since
no secretion was observed, not even the unblocked secretion of LcrV and
partial secretion of YopM seen in the
yopD mutant,
YopD's observed role in secretion must depend on a functional Ysc.
LcrQ was detected in the double mutant, as well as the
lcrD parent, irrespective of the presence of
Ca2+ (Fig. 4). These results indicate that LcrQ secretion
is not required for Yop expression to be up-regulated if YopD is
absent, which supports the idea that LcrQ alone cannot down-regulate
Yop expression.
|
LcrQ's regulatory function is dependent on YopD.
The level of
the negative regulator LcrQ within the cell has been proposed to
correlate inversely to the level of Yop expression; i.e., Yop
expression is maximal when LcrQ is depleted from the cell, whereas
elevated levels of LcrQ result in down-regulation of Yop expression
(42, 50). To determine if increased levels of LcrQ could
overcome a deletion of essentially the entire yopD gene,
lcrQ was cloned behind the arabinose-inducible promoter of
pBAD33 and introduced into both Y. pestis and Y. pestis (
yopD). No increase in LcrQ levels was
observed without induction with arabinose (Fig.
5 versus Fig. 2), indicating tight
control of expression by the promoter. Yop expression and secretion
were monitored by observing YopM levels in whole-cell and culture
supernatant fractions of cells either induced or not induced with
arabinose (Fig. 5). The level of Yop expression was constitutively
down-regulated when LcrQ was overexpressed in wild-type Y. pestis, and no secretion was detected. This is in agreement with
previously reported accounts for overexpression of LcrQ
(50). In contrast, the increased levels of LcrQ were not
sufficient to overcome the constitutively induced
yopD
phenotype: the level of YopM expression was only slightly reduced upon
strong overexpression of LcrQ (Fig. 5). This further supports the idea
that LcrQ requires YopD to exert its negative regulatory function.
However, it is possible that the small decrease in YopM expression
associated with LcrQ overexpression could reflect an inefficient or
secondary role of LcrQ alone on Yop expression.
|
yopD mutant, more was secreted than was observed
in the parent strain. This suggests that YopD may function to limit or
control the secretion of LcrQ. However, the failure of overexpressed
LcrQ to shift the phenotype of the
yopD mutant cannot be
attributed to its increased secretion, as there was still more LcrQ in
the cellular fraction of the yopD strain than is ever
present in the wild-type strain.
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we tested the hypothesis that YopD, previously shown to be necessary for Yop translocation (21, 41, 51, 58), also is a terminal negative regulator of the LCR. Our yopD null mutation resulted in constitutively induced expression of LcrV and the Yops, and provision of YopD in trans complemented this regulatory phenotype. The yopD mutant exhibited this phenotype regardless of a functioning Ysc system, demonstrating that its regulatory effect is not at the level of secretion.
Our finding that YopD is a negative regulator helps explain the phenotype originally attributed to LcrH (4, 48). A mutation in lcrH, whether polar or nonpolar, resulted in constitutive induction of the LCR (4, 48). It is now known that LcrH (also called SycD), binds to YopD and apparently stabilizes it against degradation (61). Accordingly, we can infer that the phenotype of lcrH mutants is likely due to their drastically decreased net expression of YopD. There is a previous finding that would appear to be inconsistent with this interpretation: a constitutively repressed phenotype occurred when LcrH was overexpressed in a Y. pseudotuberculosis strain with a Genblock insertion in yopD (4). However, the insertion was at the end of yopD, and perhaps enough of the YopD protein was expressed to retain its regulatory function, provided there also was extra LcrH to ensure its stability.
YopD's negative regulatory function probably operates through the action of LcrQ (also called YscM), which has previously been identified as being required for LCR down-regulation (42, 50). We showed here that YopD must be present for negative regulation to occur: in our yopD mutant, Yop expression was up-regulated, despite the fact that LcrQ was still present in the cell. In fact, overexpressing LcrQ in the yopD mutant could not overcome the observed phenotype. In addition, the inability to secrete LcrQ in the yopD ysc double mutant did not result in down-regulation of Yop expression. Therefore, we conclude that LcrQ is not sufficient for negative LCR regulation. Previous reports describing an lcrQ Y. pseudotuberculosis strain (42) indicate that YopD alone also is not sufficient, so we hypothesize that both LcrQ and YopD are necessary for LCR negative regulation.
Our data support the hypothesis that LcrQ is the limiting factor in determining whether negative regulation will occur. Previous studies documented an inverse correlation of intracellular amounts of LcrQ and expression of Yops (42, 50), and LcrQ was demonstrated to be quickly and efficiently secreted from the bacterial cell upon induction by contact with eukaryotic cells (42). We also found that the level of LcrQ in the cell seemed to directly correlate to the amount of negative LCR regulation, with the new finding that YopD had to be present. However, although YopD was necessary for negative regulation, altering its level had no significant effect on Yop expression. This is consistent with the observation that there still is YopD present in the cell under conditions of maximal LCR induction. Therefore, we hypothesize that LcrQ is rate limiting for LCR negative regulation.
YopD likely influences LcrQ function in some manner. We showed that YopD's role is not due to an indirect effect on Yop secretion, as strong secretion still occurred in the yopD mutant, and a yopD ysc double mutant also showed constitutive induction. One potential role for YopD in the translocation process is as an extracellular chaperone. In this model, YopD would be expected to bind the translocated Yops, including YopH. Because LcrQ and the amino-terminal end of YopH exhibit 42% sequence identity (50), it may be that YopD also directly binds to LcrQ. Future work will determine whether there is a direct interaction between YopD and LcrQ, as this has not yet been shown.
Interestingly, the existing data suggest that LcrQ and YopD specifically affect each other's secretion to the culture medium. We found that when LcrQ was overexpressed, only a limited amount of it was released, even though the secretion machinery was not blocked by the absence of Ca2+. The amount of overexpressed LcrQ that was secreted increased in the yopD mutant, suggesting that LcrQ secretion is affected by YopD's presence. Likewise, LcrQ is implicated in the control of YopD and LcrV secretion: an lcrQ mutant of Y. pseudotuberculosis secreted LcrV and all Yops normally in the absence of Ca2+, but in the presence of Ca2+, when secretion normally is blocked, LcrV and YopD were secreted (50). These phenomena might be manifestations of a hierarchy in the LCR induction and secretion mechanisms that could be reflected in the order in which the Yersinia proteins are secreted. A set of proteins would need to be secreted early to put in place the contact-induced translocation machinery. YopD and YopB would be among these proteins. Early LcrQ release would initiate contact-induced amplification of the antihost response while the existing pool of Yop toxins is being translocated into the host cell. Early LcrV release might be needed on two accounts: this would be one way of removing the inner secretion gate, LcrG, from its secretion-blocking location at the cytoplasmic face of the inner membrane (37); also, LcrV may play a role in translocation of Yops (38). This kind of hierarchy is supported by the phenotype of the partially secretion-defective Yersinia enterocolitica virG mutant, which, interestingly, was most severely defective in secretion of LcrV, YopB, and YopD (1). It would be of interest to examine LcrQ secretion in this mutant.
Our findings require a revision of the current model of LCR gene regulation to take into account YopD's role (Fig. 6). In the presence of Ca2+, LcrE and LcrG block the secretory machinery from outside the cell and from the cytoplasmic face, respectively, as previously proposed (13, 37). This retains both LcrQ and YopD in the cell where they can function to down-regulate LcrV and Yop expression. The possibility of additional LCR components playing a role in gene regulation cannot be ruled out with the current data (denoted in Fig. 6 by ?). The secretion block also prevents the secretion of the low levels of LcrV and Yops that are in the cell in the presence of Ca2+. The continued, albeit low-level, expression of YopD along with other LCR gene products in the absence of an inductive signal is consistent with the model, since some YopD must be expressed to function as a negative regulator even though it is subject to the same regulation. (LcrQ appears to be more Ca2+ independent in its expression [42].) Upon contact with the eukaryotic cell or removal of Ca2+ from the medium, the secretion block is relieved. It has been proposed that this occurs by LcrE sensing the change in the environment (13), which then may allow the release of some secretion system-associated LcrG (37), accompanied by the secretion of low levels of Yops, as well as LcrQ and YopD. The secretion of LcrQ occurs very efficiently (42). The decrease in intracellular levels of the negative regulators allows an increase in the expression of the LCR gene products, including LcrV. The increased level of LcrV is then able to bind to LcrG and release it from the secretion system, thereby resulting in a complete unblocking of Yop secretion. This then results in full induction of the LCR until the time when the cellular concentration of LcrQ increases to the point where it can again function as a negative regulator. Since there are still low levels of YopD present in the cell under inductive conditions, its intracellular concentration might not need to be increased for negative regulation to be reestablished.
|
There are at least two proteins required for negative control of LCR
gene expression; however, the precise mechanism of this regulation is
unknown. There is an LCR-specific transcriptional activator, LcrF
(6, 24), whose activity could potentially be affected by the
binding of a negative regulator. However, no direct interaction between
LcrF and either LcrQ or YopD has yet been documented. In the flagellar
system, where negative regulation of terminal loci in the regulatory
cascade is due to the secreted anti-sigma factor FlgM (26,
27), the signal for induction of late-gene expression derives
from monitoring the growing flagellar structure and not from an
environmental cue (33). In contrast, the LCR regulon has
previously been thought to respond to an extracellular signal, whether
it be contact with a eukaryotic cell or the absence of
Ca2+. However, the fact that YopD is known to be necessary
for vectorial translocation of effector Yops into the eukaryotic cell
raises the intriguing possibility that terminal regulation in the LCR is linked to the presence of a functional translocation mechanism at
the interface between the bacterial and eukaryotic cells. Accordingly, regulation of Yop expression at the level of transcription could be
tied to the bottom-line function of the LCR
i.e., the poisoning of the
host cell by translocation of Yops.
One similar feature between the LCR and flagellar biogenesis systems is that the signal that elicits regulation within the bacterium most likely needs to be transmitted across both inner and outer membranes, although the method of transmitting the signal likely will differ, as the structures of the secretion machineries distal to the inner membrane in the two systems do not share homology. Flagellar late-gene expression is decreased as the filament grows, due to a decrease in the rate of export of flagellar products, which is thought to result in an increase in the intracellular concentration of FlgM (26, 27). It is not clear how LCR gene regulation is terminated after induction has occurred. The analogous situation would be that as Yops are translocated into the host cell, there is a point where the rate of secretion is slowed, thereby allowing the intracellular concentration of LcrQ to increase. Alternatively, the secretion channel may again become blocked when the bacterium dissociates from the eukaryotic cell. It could be that Yersinia uses two proteins for negative regulation instead of just one to make the system more sensitive to changes in LcrQ levels. In the flagellar system, low levels of FlgM are thought to exist in the cell during flagellar late-gene expression (i.e., under inductive conditions for synthesis of the flagellar filament) (26, 27), while LcrQ is not detected in the cell upon maximal induction of the LCR. This would then require that the intracellular pool of LcrQ accumulate before the system could be shut off. YopD could be responsible for allowing the cell to respond to even very small levels of LcrQ, as under inductive conditions, YopD is the most abundant Yop. The decrease or cessation of translocation may initiate the process of LCR down-regulation by focusing YopD's function on its interaction with LcrQ.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by Public Health Service grant AI21017.
We gratefully acknowledge Wendi Gardner, Kimberly McFarland, and
El
bieta Skrzypek for the construction of pWGQ and for the preparation of anti-GST-LcrQ antibodies; Matt Nilles for construction of Y. pestis KIM8-3002; and Ken Fields for verification of
the translocation phenotype of the Y. pestis yopD mutant. We
also acknowledge Mike Russ of the University of Kentucky Macromolecular Structure Analysis Facility for the synthesis of some of the
oligonucleotides used in this study.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Albert B. Chandler Medical Center, University of Kentucky, Lexington, KY 40536-0084. Phone: (606) 323-6538. Fax: (606) 257-8994. E-mail: scstra01{at}pop.uky.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Allaoui, A.,
R. Scheen,
C. Lambert de Rouvroit, and G. R. Cornelis.
1995.
VirG, a Yersinia enterocolitica lipoprotein involved in Ca2+ dependency, is related to ExsB of Pseudomonas aeruginosa.
J. Bacteriol.
177:4230-4237 |
| 2. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1989. Analysis of proteins, p. 10.2.30. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y. |
| 3. | Beiting, M., G. V. Plano, and S. C. Straley. Unpublished data. |
| 4. |
Bergman, T.,
S. Håkansson,
Å. Forsberg,
L. Norlander,
A. Macellaro,
A. Bäckman,
I. Bölin, and H. Wolf-Watz.
1991.
Analysis of the V antigen lcrGVH-yopBD operon of Yersinia pseudotuberculosis: evidence for a regulatory role of LcrH and LcrV.
J. Bacteriol.
173:1607-1616 |
| 5. |
Bergman, T.,
K. Erickson,
E. Golyov,
C. Persson, and H. Wolf-Watz.
1994.
The lcrB (yscN/U) gene cluster of Yersinia pseudotuberculosis is involved in Yop secretion and shows high homology to the spa gene clusters of Shigella flexneri and Salmonella typhimurium.
J. Bacteriol.
176:2619-2626 |
| 6. | Cornelis, G. R., C. Sluiters, I. Delor, D. Geib, K. Keniga, C. Lambert de Rouvroit, M.-P. Sory, J. C. Vanootegehem, and T. Michiels. 1991. ymoA, a Yersinia enterocolitica chromosomal gene modulating the expression of virulence functions. Mol. Microbiol. 5:1023-1034[Medline]. |
| 7. |
Cornelis, G. R.,
C. Sluiters,
C. Lambert de Rouvroit, and T. Michiels.
1989.
Homology between VirF, the transcriptional activator of the Yersinia virulence region, and the Escherichia coli arabinose operon regulator.
J. Bacteriol.
171:254-262 |
| 8. | Cornelis, G. R., and H. Wolf-Watz. 1997. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol. Microbiol. 23:861-867[Medline]. |
| 9. |
Ferber, D. M., and R. R. Brubaker.
1981.
Plasmids in Yersinia pestis.
Infect. Immun.
31:839-841 |
| 10. |
Fields, K. A.,
G. V. Plano, and S. C. Straley.
1994.
A low-Ca2+ response (LCR) secretion (ysc) locus lies within the lcrB region of the LCR plasmid in Yersinia pestis.
J. Bacteriol.
176:569-579 |
| 11. | Fields, K. A., and S. C. Straley. Unpublished data. |
| 12. | Fields, K. A., A. W. Williams, and S. C. Straley. 1997. Failure to detect binding of LcrH to the V antigen of Yersinia pestis. Infect. Immun. 65:3954-3957[Abstract]. |
| 13. | Forsberg, Å, A.-M. Viitanen, M. Skurnik, and H. Wolf-Watz. 1991. The surface-located YopN protein is involved in calcium signal transduction in Yersinia pseudotuberculosis. Mol. Microbiol. 5:977-986[Medline]. |
| 14. | Gardner, W., E. Skrzypek, and S. C. Straley. Unpublished data. |
| 15. |
Goguen, J. D.,
J. Yother, and S. C. Straley.
1984.
Genetic analysis of the low calcium response in Yersinia pestis Mud1 (Ap lac) insertion mutants.
J. Bacteriol.
160:842-848 |
| 16. |
Guzman, L.-M.,
D. Berlin,
M. J. Carson, and J. Beckwith.
1995.
Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter.
J. Bacteriol.
177:4121-4130 |
| 17. |
Håkansson, S.,
T. Bergman,
J.-C. Vanooteghem,
G. Cornelis, and H. Wolf-Watz.
1993.
YopB and YopD constitute a novel class of Yersinia Yop proteins.
Infect. Immun.
61:71-81 |
| 18. | Håkansson, S., E. E. Galyov, R. Rosqvist, and H. Wolf-Watz. 1996. The Yersinia YpkA Ser/Thr kinase is translocated and subsequently targeted to the inner surface of the HeLa cell plasma membrane. Mol. Microbiol. 20:593-603[Medline]. |
| 19. | Håkansson, S., C. Persson, K. Schesser, E. E. Galyov, R. Rosqvist, and H. Wolf-Watz. 1996. The YopB protein of Yersinia pseudotuberculosis is essential for translocation of Yop effector proteins across the target cell plasma membrane and displays contact-dependent membrane-disrupting activity. EMBO J. 15:5812-5823[Medline]. |
| 20. | Hanahan, D. 1983. Studies on transformation of E. coli with plasmids. J. Mol. Biol. 166:557-580[Medline]. |
| 21. |
Hartland, E. L.,
S. P. Green,
W. A. Philips, and R. M. Robins-Browne.
1994.
Essential role of YopD in inhibition of the respiratory burst of macrophages by Yersinia enterocolitica.
Infect. Immun.
62:4445-4453 |
| 22. | Hartland, E. L., A.-M. Bordun, and R. M. Robins-Browne. 1996. Contributions of YopB to virulence of Yersinia enterocolitica. Infect. Immun. 64:2308-2314[Abstract]. |
| 23. | Higuchi, R. 1990. Recombinant PCR, p. 177-183. In M. A. Innis, D. H. Gelfand, J. J. Sninsky, and T. J. White (ed.), PCR protocols: a guide to methods and applications. Academic Press, San Diego, Calif. |
| 24. |
Hoe, N. P., and J. D. Goguen.
1993.
Temperature sensing in Yersinia pestis: translation of the LcrF activator protein is thermally regulated.
J. Bacteriol.
175:7901-7909 |
| 25. | Holmström, A., J. Pettersson, R. Rosqvist, S. Håkansson, F. Tafazoli, M. Fällman, K.-E. Magnusson, H. Wolf-Watz, and Å. Forsberg. 1997. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane. Mol. Microbiol. 24:73-91[Medline]. |
| 26. |
Hughes, K. T.,
K. L. Gillen,
M. J. Semon, and J. E. Karlinsey.
1993.
Sensing structural intermediates in bacterial flagellar assembly by export of a negative regulator.
Science
262:1277-1280 |
| 27. | Kutsukake, K. 1994. Excretion of the anti-sigma factor through a flagellar structure couples flagellar gene expression with flagellar assembly in Salmonella typhimurium. Mol. Gen. Genet. 243:605-612[Medline]. |
| 28. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[Medline]. |
| 29. | Lambert de Rouvroit, C., C. Sluiters, and G. R. Cornelis. 1992. Role of the transcriptional activator VirF in the expression of the pYV plasmid genes of Yersinia enterocolitica. Mol. Microbiol. 6:395-409[Medline]. |
| 30. | Lee, C. A. 1997. Type III secretion systems: machines to deliver bacterial proteins into eukaryotic cells? Trends Microbiol. 5:148-156[Medline]. |
| 31. | Levesque, C., L. Piche, L. Chantal, and P. H. Roy. 1995. PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob. Agents Chemother. 39:185-191[Abstract]. |
| 32. |
Lindler, L. E.,
M. S. Klempner, and S. C. Straley.
1990.
Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague.
Infect. Immun.
58:2569-2577 |
| 33. | Macnab, R. M. 1996. Flagella and motility, p. 123-145. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C. |
| 34. |
Miller, V. L., and J. J. Mekalanos.
1988.
A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR.
J. Bacteriol.
170:2575-2583 |
| 35. | Moore, J. T., A. Uppal, F. Maley, and G. F. Maley. 1993. Overcoming inclusion body formation in a high-level expression system. Protein Expr. Purif. 4:160-163[Medline]. |
| 36. | Nemeth, J., and S. C. Straley. 1997. Effect of Yersinia pestis YopM on experimental plague. Infect. Immun. 65:924-930[Abstract]. |
| 37. |
Nilles, M. L.,
A. W. Williams,
E. Skrzypek, and S. C. Straley.
1997.
Yersinia pestis LcrV forms a stable complex with LcrG and may have a secretion-related regulatory role in the low-Ca2+ response.
J. Bacteriol.
179:1307-1316 |
| 38. | Nilles, M. L., and S. C. Straley. Unpublished data. |
| 39. |
Perry, R. D.,
M. Pendrak, and P. Schuetze.
1990.
Identification and cloning of a hemin storage locus involved in the pigmentation phenotype of Yersinia pestis.
J. Bacteriol.
172:5929-5937 |
| 40. |
Perry, R. D., and J. D. Fetherston.
1997.
Yersinia pestis etiologic agent of plague.
Clin. Microbiol. Rev.
10:35-66[Abstract].
|
| 41. | Persson, C., R. Nordfelth, N. Holmström, S. Håkansson, R. Rosqvist, and H. Wolf-Watz. 1995. Cell-surface-bound Yersinia translocate the protein tyrosine phosphatase YopH by a polarized mechanism into the target cell. Mol. Microbiol. 18:135-150[Medline]. |
| 42. | Pettersson, J., R. Nordfelth, E. Dubinina, T. Bergman, M. Gustavsson, K.-E. Magnusson, and H. Wolf-Watz. 1996. Modulation of virulence factor expression by pathogen target cell contact. Science 273:1231-1233[Abstract]. |
| 43. |
Plano, G. V.,
S. S. Barve, and S. C. Straley.
1991.
LcrD, a membrane-bound regulator of the Yersinia pestis low-calcium response.
J. Bacteriol.
173:7293-7303 |
| 44. |
Plano, G. V., and S. C. Straley.
1993.
Multiple effects of lcrD mutations in Yersinia pestis.
J. Bacteriol.
175:3536-3545 |
| 45. |
Plano, G. V., and S. C. Straley.
1995.
Mutations in yscC, yscD, and yscG prevent high-level expression and secretion of V antigen and Yops in Yersinia pestis.
J. Bacteriol.
177:3843-3854 |
| 46. | Price, S. B., C. Cowan, R. D. Perry, and S. C. Straley. 1991. The Yersinia pestis V antigen is a regulatory protein necessary for Ca2+-dependent growth and maximal expression of low-Ca2+ response virulence genes. J. Bacteriol. 173:1491-1498. |
| 47. |
Price, S. B.,
K. Y. Leung,
S. S. Barve, and S. C. Straley.
1989.
Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis.
J. Bacteriol.
171:5646-5653 |
| 48. |
Price, S. B., and S. C. Straley.
1989.
lcrH, a gene necessary for virulence of Yersinia pestis and for the normal response of Y. pestis to ATP and calcium.
Infect. Immun.
57:1491-1498 |
| 49. | Protsenko, O. A., P. I. Anisimov, O. T. Mozharov, N. P. Konnov, Y. A. Popov, and A. M. Kokookshkin. 1983. Detection and characterization of Yersinia pestis plasmids determining pesticin I, fraction I antigen and mouse toxin synthesis. Genetika 19:1081-1090[Medline]. |
| 50. |
Rimpiläinen, M.,
Å. Forsberg, and H. Wolf-Watz.
1992.
A novel protein, LcrQ, involved in the low-calcium response of Yersinia pseudotuberculosis, shows extensive homology to YopH.
J. Bacteriol.
174:3355-3363 |
| 51. | Rosqvist, R., K.-E. Magnusson, and H. Wolf-Watz. 1994. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 13:964-972[Medline]. |
| 52. | Salmond, G. P. C., and P. J. Reeves. 1993. Membrane traffic wardens and protein secretion in Gram-negative bacteria. Trends Biochem. Sci. 18:7-12[Medline]. |
| 53. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. . Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 54. | Skrzypek, E., P. L. Haddix, G. V. Plano, and S. C. Straley. 1993. New suicide vector for gene replacement in yersiniae and other gram-negative bacteria. Plasmid 29:160-163[Medline]. |
| 55. |
Skrzypek, E., and S. C. Straley.
1993.
LcrG, a secreted protein involved in negative regulation of the low-calcium response in Yersinia pestis.
J. Bacteriol.
175:3520-3528 |
| 56. |
Skrzypek, E., and S. C. Straley.
1995.
Differential effects of deletions in lcrV on secretion of V antigen, regulation of the low-Ca2+ response, and virulence of Yersinia pestis.
J. Bacteriol.
177:2530-2542 |
| 57. |
Sodeinde, O. A., and J. D. Goguen.
1988.
Genetic analysis of the 9.5-kilobase virulence plasmid of Yersinia pestis.
Infect. Immun.
56:2743-2748 |
| 58. | Sory, M.-P., and G. R. Cornelis. 1994. Translocation of a hybrid YopE-adenylate cyclase from Yersinia enterocolitica into HeLa cells. Mol. Microbiol. 14:583-594[Medline]. |
| 59. |
Straley, S. C., and W. S. Bowmer.
1986.
Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins.
Infect. Immun.
51:445-454 |
| 60. |
Une, T., and R. R. Brubaker.
1984.
In vivo comparison of avirulent Vwa and Pgm or Pstr phenotypes of yersiniae.
Infect. Immun.
43:895-900 |
| 61. |
Wattiau, P.,
B. Bernier,
P. Deslée,
T. Michiels, and G. R. Cornelis.
1994.
Individual chaperones required for Yop secretion by Yersinia.
Proc. Natl. Acad. Sci. USA
91:10493-10497 |
| 62. | Williams, A. W., and S. C. Straley. Unpublished data. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»